Filters: First Letter Of Last Name is R [Clear All Filters]
Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International journal of oncology. 2007;30(5):1099-107.
A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer. British journal of cancer. 2011;105(1):53-7.
Health impacts of long-term exposure to disinfection by-products in drinking water in Europe: HIWATE. Journal of water and health. 2009;7(2):185-207.
High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation. Gastroenterology. 2011;140(7):1919-26.
Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer causes & control : CCC. 2010;21(5):737-43.
Identification of Lynch syndrome among patients with colorectal cancer. JAMA : the journal of the American Medical Association. 2012;308(15):1555-65.
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment. Breast cancer research and treatment. 2010;119(1):33-8.
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. British journal of haematology. 2012;158(6):805-9.
The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe. Journal of hepatology. 2008;49(2):233-42.
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS biology. 2011;9(11):e1001199.
Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30.
Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41.
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Human genetics. 2012;131(2):217-34.
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(20):3468; author reply 3468-9.
MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. Cancer research. 2010;70(19):7379-91.
Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes, chromosomes & cancer. 2007;46(2):155-62.
MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Cancer research. 2011;71(7):2632-42.
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 2007;28(6):1241-6.
Nanofluidic Digital PCR for KRAS Mutation Detection and Quantification in Gastrointestinal Cancer. Clinical chemistry. 2012;58(9):1332-41.
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007;39(11):1338-49.
No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations. British journal of cancer. 2011;104(4):735-40.
Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clinical colorectal cancer. 2010;9(3):168-76.
Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. Inflammatory bowel diseases. 2012.